-+ 0.00%
-+ 0.00%
-+ 0.00%

GILEAD RECEIVES CHMP POSITIVE OPINION FOR TRODELVY® IN FIRST-LINE METASTATIC TRIPLE-NEGATIVE BREAST CANCER FOR PATIENTS NOT CANDIDATES FOR PD-(L)1 INHIBITORS

Reuters·05/22/2026 11:47:05

Please log in to view news